Vaxcyte Inc (NASDAQ: PCVX) kicked off on Tuesday, up 3.16% from the previous trading day, before settling in for the closing price of $112.11. Over the past 52 weeks, PCVX has traded in a range of $44.20-$121.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded -3.36%. With a float of $116.65 million, this company’s outstanding shares have now reached $121.80 million.
Considering the fact that the conglomerate employs 254 people, you should pay attention to its efficiency factor.
Vaxcyte Inc (PCVX) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Vaxcyte Inc is 4.23%, while institutional ownership is 98.00%. The most recent insider transaction that took place on Sep 18 ’24, was worth 927,551. In this transaction PRESIDENT AND CFO of this company sold 8,000 shares at a rate of $115.94, taking the stock ownership to the 90,383 shares. Before that another transaction happened on Sep 17 ’24, when Company’s Director sold 6,250 for $116.28, making the entire transaction worth $726,731. This insider now owns 7,175 shares in total.
Vaxcyte Inc (PCVX) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 6/30/2024, the organization reported -0.91 earnings per share (EPS), lower than consensus estimate (set at -0.84) by -0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -1.24 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -3.36% per share during the next fiscal year.
Vaxcyte Inc (NASDAQ: PCVX) Trading Performance Indicators
Take a look at Vaxcyte Inc’s (PCVX) current performance indicators. Last quarter, stock had a quick ratio of 17.88.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -4.76, a number that is poised to hit -1.11 in the next quarter and is forecasted to reach -4.88 in one year’s time.
Technical Analysis of Vaxcyte Inc (PCVX)
Compared to the last year’s volume of 0.85 million, its volume of 1.0 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 27.26%. Additionally, its Average True Range was 4.67.
During the past 100 days, Vaxcyte Inc’s (PCVX) raw stochastic average was set at 90.67%, which indicates a significant increase from 52.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 30.39% in the past 14 days, which was lower than the 59.51% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $90.38, while its 200-day Moving Average is $73.95. Nevertheless, the first resistance level for the watch stands at $117.46 in the near term. At $119.28, the stock is likely to face the second major resistance level. The third major resistance level sits at $122.77. If the price goes on to break the first support level at $112.15, it is likely to go to the next support level at $108.66. Should the price break the second support level, the third support level stands at $106.84.
Vaxcyte Inc (NASDAQ: PCVX) Key Stats
The company with the Market Capitalisation of 14.09 billion has total of 108,795K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -402,270 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -128,700 K.
